A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke

Terminated

Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to determine whether a new research medication is effective and safe for the treatment of acute stroke when given within 6 hours of the onset of stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 June 2006.

1 Sep 2003 21 Nov 2003 Unavailable 1 Feb 2005 1 Jun 2006 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available